Pembroke, Bermuda - 22 October 2025
("
Notice of Trading Update for Q3 2025
Presentation for Analysts and Investors
Investor Presentation via
Presentation for Analysts and Investors at
Conduit's management will host a virtual meeting for analysts and investors, via a webcast and conference call, on Wednesday,
To access the webcast, please register in advance here:
To access the conference call, please register to receive unique dial-in details here:
https://registrations.events/direct/LON689779
A recording of the presentation will be made available later in the day on the Investors section of Conduit's website at www.conduitreinsurance.com.
Investor Presentation via
Conduit's management will provide a separate presentation aimed at retail investors, relating to the Q3 2025 trading update, via the
The presentation is open to all existing and potential shareholders. No new material, including trading or financial information, will be disclosed during the presentation.
There will be an opportunity for questions and answers at the end of the presentation. Questions can be submitted pre-event via the
Investors can sign up to
https://www.investormeetcompany.com/conduit-holdings-limited/register-investor
Investors who are already registered on the
Media contacts:
+44 (0) 207 562 4444
Investor relations and other enquiries:
+44 (0) 207 886 2500
Berenberg (Joint Corporate Broker)
+44 (0) 203 207 7800
Peel Hunt (Joint Corporate Broker)
+44 (0) 207 418 8900
About Conduit Re
Conduit Re is a
Learn more about Conduit Re:
Website: https://conduitreinsurance.com/
LinkedIn: https://www.linkedin.com/company/conduit-re
Neither the content of Conduit's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a regulated information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the